Independent patent research and strategic IP insights for medtech, biosensors, and diagnostics.
Prior art assessment focused on novelty and inventive step. Suitable for early-stage concepts in medical devices, biosensors, and diagnostics.
From €400
More info
Structured risk review with claim-level reading and legal status checks. Includes practical design-around considerations.
From €2,500
More info
Competitor and technology intelligence with market perspective. Concise, decision-oriented briefs rather than data dumps.
Custom pricing
More info
Targeted prior art and context to assess the strength of granted patents for opposition, invalidation, or licensing discussions.
Custom pricing
More info
Short consultation to clarify objectives, scope, and jurisdictions.
Use of professional databases such as Questel Orbit, PatSnap, and Lens.org, combined with subject-matter expertise.
Concise deliverables tailored to engineers, management, or investors, with clear next-step options.
IPvera is an independent, expert-led patent research service founded by Dr. Anders Henriksson, specializing in medtech, biosensors, diagnostics, and implantables.
Experience across academia, industry, and technology transfer in Austria, Germany, and Japan. The focus is on reliable analysis with practical relevance for R&D and business decisions.
IPvera does not provide legal advice and collaborates with patent attorneys as needed to ensure legally relevant outcomes.
Artificial intelligence is integrated where it adds value—broadening and accelerating searches, clustering results, and surfacing connections. Interpretation and conclusions are performed by an expert to ensure reliability.
This combination reduces time and cost without compromising quality.
Email: info@ipvera.com
By submitting this form, you agree to our Terms and Conditions (AGB) and Privacy Policy.